Usefulness of Dofetilide for the Prevention of Atrial Tachyarrhythmias (Atrial Fibrillation or Flutter) After Coronary Artery Bypass Grafting

American Journal of Cardiology

Volumn 101, Issue 11, 2008, Pages 1574-1579

  Serafimovski, Nenad ^a   Burke, Peter ^a   Khawaja, Owais ^a   Sekulic, Milan ^a   Machado, Christian ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOFETILIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES;

AGED; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MICHIGAN; PHENETHYLAMINES; POSTOPERATIVE COMPLICATIONS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RETROSPECTIVE STUDIES; SULFONAMIDES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 44649118636     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.01.044     Document Type: Article

References (27)

1. McClellan K.J., and Markham A. Dofetilide. A review of its use in atrial fibrillation and atrial flutter. Drugs 58 (1999) 1043-1059
2. Tsikouris J.P. Focus on dofetilide: a selective class III antiarrhythmic agent for use in atrial fibrillation or atrial flutter. Formulary 33 (1998) 1066-1081
3. Singh S., Zoble R.G., Yellen L., Brodsky M.A., Feld G.K., Berk M., and Billing C.B. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter. The symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study. Circulation 102 (2000) 2385-2390
4. Roukoz H., and Saliba W. Dofetilide: a new class III antiarrhythmic agent (review). Exp Rev Cardiovasc Ther 5 (2007) 9-19
5. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E., Kober L., Sandoe E., Egstrup K., Agner E., Carlsen J., Videbaek J., Marchant B., and Camm J.A. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. For the Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. The DIAMOND-CHF study. N Engl J Med 341 (1999) 857-865
6. Pritchett E.L., and Wilkinson W.E. Effect of dofetilide on survival in patients with supraventricular arrhythmias. Am Heart J 138 (1999) 994-997
7. Frost L., Mortensen P.E., Tingleff J., Platou E.S., Christiansen E.H., and Christiansen N. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group. Int J Cardiol 58 (1997) 135-140
8. Kober L., Bloch-Thomsen P.E., Moller M., Torp-Pedersen C., Carlsen J., Sandoe E., Egstrup K., Agner E., Videbaek J., Merchant B., Camm A.J., and Danish Investigation of Arrhythmia and Mortality on Dofetilide (Diamond) Study Group. Effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction: results of the DIAMOND-MI study. Lancet 356 (2000) 2052-2058
9. Pedersen O.D., Bagger H., Keller N., Marchant B., Kober L., and Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function. A Danish Investigation of Arrhythmia and Mortality on Dofetilide (DIAMOND) substudy. Circulation 104 (2001) 292-296
10. Andrews T.C., Reimold S.C., Berlin J.A., and Antman E.M. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 84 suppl III (1991) III236-III244
11. Ommen S.R., Odell J.A., and Stanton M.S. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336 (1997) 1429-1434
12. Wurdeman R.L., Mooss A.N., Mohiuddin S.M., and Lenz T.L. Amiodarone vs sotolol as prophylaxis against atrial fibrillation/flutter after heart sugery. A meta-analysis. Chest 121 (2002) 1203-1210
13. Crystal E., Connolly S.J., Sleik K., Ginger T.J., and Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery. A meta-analysis. Circulation 106 (2002) 75-80
14. Mathew J.P., Fontes M.L., Tudor I.C., Ramsay J., Duke P., Mazer C.D., Barash P.G., Hsu P.H., and Mangano D.T. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291 (2004) 1720-1728
15. Bradley D., Creswell L.L., Hogue C.W., Epstein A.E., Prystowsky E.N., and Daoud E.G. Pharmacologic prophylaxis. American College of Chest Physicians guidelines for the prevention of postoperative atrial fibrillation after cardiac surgery. Chesty 128 suppl (2005) 39S-47S
16. Aasbo J.D., Lawrence A.T., Krishnan K., Kim M.H., and Trohman R.G. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann Intern Med 143 (2005) 327-336
17. Mitchell B.L., Exner D.V., Wyse D.G., Connolly C.J., Prystai G.D., Bayes A.J., Kidd W.T., Kieser T., Burgess J.J., Ferland A., MacAdams C.L., and Maitland A. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair. PAPABEAR: a randomized controlled trial. JAMA 294 (2005) 3093-3100
18. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H.J., Frye R.L., Halperin J.L., Kay G.N., Klein W.W., Levy S., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 38 (2001) 1266l-1266lii
19. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., LeHeuzey J.-Y., Kay G.N., Lowe J.E., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 48 (2006) e213-e215
20. Zimmer J., Pezzullo J., Choucair W., Southard J., Kokkinos P., Karasik P., Greenberg M.D., and Singh S.N. Meta-analysis of antiarrhythmic therapy in the postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol 91 (2003) 1137-1140
21. Gomes J.A., Ip J., Santoni-Rugiu F., Mehta D., Ergin A., Lansman S., Pe E., Newhouse T.T., and Chao S. Sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery; a randomized double blind, placebo-controlled study. J Am Coll Cardiol 34 (1999) 334-339
22. Daoud E.G., Strickberger S.A., Man K.C., Goyal R., Deeb G.M., Bolling S.F., Pangani F.D., Bitar C., Meissner M.D., and Morady F. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337 (1997) 1785-1791
23. Creswell L.L., Schuessler R.B., Rosenbloom M., and Cox J.L. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56 (1993) 539-549
24. Maisel W.H., Rawn J.D., and Stevenson W.G. Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001) 1061-1073
25. Villareal R.P., Hariharan R., Liu B.C., Kar B., Lee V., Elayda M., Lopez A., Rasekh A., Wilson J.M., and Massumi A. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 43 (2004) 742-748
26. Hogue C.W., Creswell L.L., Gutterman D.D., and Fleisher L.A. Epidemiology, mechanisms, and risks. American College of Chest Physicians guidelines for the prevention of postoperative atrial fibrillation after cardiac surgery. Chest 128 suppl (2005) 9S-16S
27. Kowey P.R., Stebbins D., Igidbashian L., Goldman S.M., Sutter F.P., Rials S.J., and Marinchak R.A. Clinical outcome of patients who develop PAF after CABG surgery. Pacing Clin Electrophysiol 24 (2001) 191-193